{
  "id": 19382727,
  "title": "Gain Therapeutics Q3 Loss Narrows",
  "url": "https://urgent.news/2026/11/10/gain-therapeutics-q3-loss-narrows",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-10T18:48:57.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/gain-therapeutics-q3-loss-narrows"
  },
  "original_language": "en",
  "account": null,
  "summary": "(RTTNews) - Gain Therapeutics, Inc. (GANX) on Tuesday reported a narrower net loss for the third quarter of 2026 compared with the same period in 2025, as reduced research and development and general and administrative expenses lowered overall operating costs.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 1,
    "also_reported_by": []
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}